Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ferris

Showing results (421-430 of 460) with videos related to

Pageof 46
Sort By:
Circulation. Cardiovascular Quality and Outcomes|May 13, 2020
Association of an Acute Myocardial Infarction Readmission-Reduction Program With Mortality and ReadmissionJason H Wasfy, Michael K Hidrue, Jacqueline Ngo, et al.
Pediatrics|November 24, 2017
4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 YearsDaron G Ferris, Rudiwilai Samakoses, Stanley L Block, et al.
Obstetrics and Gynecology|August 2, 2007
Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trialCharles H Livengood, Daron G Ferris, Harold C Wiesenfeld, et al.
Health Affairs (Project Hope)|July 7, 2017
A Systematic Intervention To Improve Serious Illness Communication In Primary CareJoshua R Lakin, Luca A Koritsanszky, Rebecca Cunningham, et al.
Journal of Medicinal Chemistry|July 31, 2008
Structural basis for the improved drug resistance profile of new generation benzophenone non-nucleoside HIV-1 reverse transcriptase inhibitorsJingshan Ren, Philip P Chamberlain, Anna Stamp, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 10, 2010
Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young womenRalph P Insinga, Gonzalo Perez, Cosette M Wheeler, et al.
Gynecologic Oncology|January 21, 2020
Better survival is observed in cervical cancer patients positive for specific anti-glycan antibodies and receiving brachytherapySharad Purohit, Daron G Ferris, Manual Alvarez, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro selection for resistanceRichard J Hazen, Robert J Harvey, Marty H St Clair, et al.
Vaccine|July 9, 2013
Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in malesStephen E Goldstone, Heiko Jessen, Joel M Palefsky, et al.
Journal of Medicinal Chemistry|January 20, 2006
Structure-activity relationship studies of novel benzophenones leading to the discovery of a potent, next generation HIV nonnucleoside reverse transcriptase inhibitorKaren R Romines, George A Freeman, Lee T Schaller, et al.
Pageof 46

Showing results (421-430 of 460) with videos related to

Sort By:
Pageof 46
Circulation. Cardiovascular Quality and Outcomes|May 13, 2020
Association of an Acute Myocardial Infarction Readmission-Reduction Program With Mortality and ReadmissionJason H Wasfy, Michael K Hidrue, Jacqueline Ngo, et al.
Pediatrics|November 24, 2017
4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 YearsDaron G Ferris, Rudiwilai Samakoses, Stanley L Block, et al.
Obstetrics and Gynecology|August 2, 2007
Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trialCharles H Livengood, Daron G Ferris, Harold C Wiesenfeld, et al.
Health Affairs (Project Hope)|July 7, 2017
A Systematic Intervention To Improve Serious Illness Communication In Primary CareJoshua R Lakin, Luca A Koritsanszky, Rebecca Cunningham, et al.
Journal of Medicinal Chemistry|July 31, 2008
Structural basis for the improved drug resistance profile of new generation benzophenone non-nucleoside HIV-1 reverse transcriptase inhibitorsJingshan Ren, Philip P Chamberlain, Anna Stamp, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 10, 2010
Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young womenRalph P Insinga, Gonzalo Perez, Cosette M Wheeler, et al.
Gynecologic Oncology|January 21, 2020
Better survival is observed in cervical cancer patients positive for specific anti-glycan antibodies and receiving brachytherapySharad Purohit, Daron G Ferris, Manual Alvarez, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro selection for resistanceRichard J Hazen, Robert J Harvey, Marty H St Clair, et al.
Vaccine|July 9, 2013
Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in malesStephen E Goldstone, Heiko Jessen, Joel M Palefsky, et al.
Journal of Medicinal Chemistry|January 20, 2006
Structure-activity relationship studies of novel benzophenones leading to the discovery of a potent, next generation HIV nonnucleoside reverse transcriptase inhibitorKaren R Romines, George A Freeman, Lee T Schaller, et al.
Pageof 46